Iron deficiency drives metabolic adaptation of red pulp macrophages via ferroportin-SYK signaling and BCAA catabolism to enhance erythrophagocytosis

Iron deficiency triggers a ferroportin-SYK signaling-dependent metabolic reprogramming in splenic red pulp macrophages via branched-chain amino acid catabolism, which enhances their mitochondrial respiration and erythrophagocytic capacity to maintain systemic iron homeostasis.

The Gist

Imagine your body is a bustling city, and Iron is the most valuable currency in that city. It's essential for building the delivery trucks (red blood cells) that carry oxygen to every neighborhood.

When the city runs low on this currency (Iron Deficiency), the economy gets tight. Usually, we think of the "Iron Recycling Center"—a specialized team of workers called Red Pulp Macrophages (RPMs) located in the spleen—as just passive recyclers. Their job is to take old, worn-out delivery trucks, strip them for parts (iron), and send those parts back to the factory.

This paper reveals a surprising twist: When the city is starving for iron, these recycling workers don't just work harder; they undergo a complete superhero transformation. They become hyper-efficient, high-speed recyclers, but they need a very specific fuel to do it.

Here is the story of how they do it, broken down into simple steps:

1. The "Open Door" Policy (The Signal)

Normally, the city has a strict gatekeeper (a hormone called Hepcidin) that tells the recycling workers, "Close the doors! Don't let the iron out yet."

• In Iron Deficiency: The gatekeeper goes on vacation. The doors (a protein called Ferroportin) swing wide open.
• The Result: The workers realize, "Hey, the boss is gone! We need to get this iron out fast to keep the city running." This opens the floodgates for a new kind of activity.

2. The "Super-Recycling" Mode (Erythrophagocytosis)

With the doors open, the workers realize they need to grab more old trucks to break down.

• The Change: They suddenly become incredibly fast at eating old red blood cells. It's like a garbage truck driver who usually picks up one bag a day suddenly deciding to pick up a whole dumpster every hour.
• The Goal: By breaking down more trucks, they release more iron into the bloodstream to fix the shortage.

3. The Engine Upgrade (Metabolic Rewiring)

You can't run a high-speed recycling plant on a weak engine. Usually, when cells are stressed, they slow down. But these workers do the opposite: they upgrade their engines.

• The Upgrade: They build more mitochondria (the cell's power plants) and rev them up to maximum speed. They are burning fuel at a furious rate to power this super-speed recycling.
• The Secret Fuel: Here is the biggest surprise. Most cells run on sugar or fat. But these iron-recycling workers discovered a secret super-fuel: BCAAs (Branched-Chain Amino Acids).
  • Analogy: Imagine a race car that usually runs on gasoline. But when the track gets slippery (low iron), the driver switches to a special, high-octane rocket fuel found inside the old trucks they are recycling. This fuel allows them to run faster than ever before.

4. The Ignition Switch (The SYK Signal)

How do they know when to switch to this super-fuel and rev the engine?

• The Switch: There is a tiny internal switch called SYK. When the "Open Door" signal (Ferroportin) is active, it flips the SYK switch.
• The Chain Reaction: Flipping SYK tells the cell: "Switch to BCAA fuel! Build more engines! Eat more trucks!"
• The Proof: When the scientists turned off this switch (using a drug), the workers went back to being slow and lazy, even if they were starving for iron. The whole system collapsed.

5. Why This Matters

This isn't just about cells; it's about survival.

• The Big Picture: This paper shows that our body has a brilliant, automatic backup plan for when iron is low. The recycling centers in the spleen don't just wait for instructions; they actively rewire their own metabolism to become iron-recycling machines.
• The Catch: This system is unique to the spleen. The liver and other parts of the body don't do this. It's a specialized team with a specialized job.

The Takeaway

Think of Iron Deficiency not just as a "lack of fuel," but as a call to action.

1. The Gatekeeper (Hepcidin) steps aside.
2. The Doors (Ferroportin) open wide.
3. The Switch (SYK) gets flipped.
4. The Workers (RPMs) switch to Rocket Fuel (BCAAs).
5. They Eat the old trucks faster than ever to save the city.

This discovery is huge because it explains how our body adapts to anemia at a cellular level. It suggests that if we can understand or tweak this "Rocket Fuel" pathway, we might be able to help people with iron deficiency or anemia recover faster, or perhaps even help other types of immune cells work better in different diseases.

Technical Summary

1. Problem Statement

Iron deficiency (ID) is the most common nutritional disorder globally, leading to anemia. While the systemic effects of ID are well-documented, the specific cellular mechanisms by which splenic red pulp macrophages (RPMs)—the primary cells responsible for recycling iron from senescent red blood cells (RBCs)—adapt to iron scarcity remain unclear.

• The Gap: It is unknown how RPMs adjust their clearance capacity (erythrophagocytosis) and metabolic programs when systemic iron is low.
• The Paradox: Previous studies suggest iron deprivation generally suppresses macrophage function or induces a pro-inflammatory state. However, the physiological need during ID is to increase iron recycling to support erythropoiesis. The signaling and metabolic pathways driving this adaptive enhancement in RPMs were previously undefined.

2. Methodology

The study employed a multi-faceted approach combining in vivo mouse models, in vitro cell culture systems, and advanced omics technologies:

• Animal Models:
  • Nutritional ID Model: Female C57BL/6J mice fed an iron-deficient diet (<5 ppm) vs. iron-balanced (IB) control (200 ppm) for 5 weeks.
  • Genetic Models: Tmprss6 knockout mice (model of iron-refractory iron deficiency anemia with high hepcidin) to distinguish the effects of low iron vs. low hepcidin.
  • Reporter Mice: Ms4a3-Cre-RosaTdT mice to track embryonic vs. monocyte-derived RPMs.
• Cell Culture Systems:
  • iRPMs: Bone marrow-derived macrophages differentiated with M-CSF and hemin to mimic the iron-rich, heme-processing phenotype of splenic RPMs.
  • Serum Transfer: Culturing iRPMs in serum from ID vs. IB mice to identify soluble factors.
  • Genetic Manipulation: Lentiviral overexpression of Ferroportin (FPN) and site-directed mutagenesis (D39A mutant) to test Ca²⁺ transport capabilities.
• Pharmacological Interventions:
  • PR73: A hepcidin mimetic to acutely suppress FPN.
  • Vamifeport: A specific FPN inhibitor.
  • Entospletinib (ENTO): A selective SYK kinase inhibitor.
  • ERG240 & BAY069: Inhibitors of Branched-Chain Amino Acid (BCAA) catabolism (BCAT enzyme).
  • Trimetazidine (TMZ): Inhibitor of CPT2 (β-oxidation).
• Analytical Techniques:
  • Omics: RNA-seq and TMT-based quantitative proteomics on FACS-sorted RPMs.
  • Functional Assays: Flow cytometry for erythrophagocytosis (using PKH/PKH26-labeled stressed RBCs), mitochondrial respiration (Seahorse XF), lysosomal activity, and metabolic flux (MitoPlate S-1).
  • Imaging: Live-cell imaging (pHrodo dye), confocal microscopy, and Transmission Electron Microscopy (TEM).

3. Key Contributions & Findings

A. Enhanced Erythrophagocytosis in Iron Deficiency

• Observation: RPMs from ID mice exhibit a significant increase in erythrophagocytic capacity (clearance of stressed RBCs) compared to IB controls.
• Specificity: This enhancement is specific to RPMs; liver Kupffer cells (KCs) and peritoneal macrophages do not show this adaptation.
• Mechanism: The increase is driven by cell-intrinsic changes in RPMs, not by increased "eat-me" signals from RBCs (RBC lifespan and phosphatidylserine exposure were unchanged).

B. Metabolic Reprogramming: A Non-Canonical State

• Mitochondrial & Lysosomal Expansion: Proteomics and flow cytometry revealed expanded mitochondrial networks (increased mass, membrane potential, and OXPHOS) and enhanced lysosomal biogenesis (CLEAR network upregulation).
• Distinct from M1/M2: The RPMs in ID do not fit canonical M1 (pro-inflammatory) or M2 (anti-inflammatory) polarization profiles. They display a unique "hybrid" state with high ROS (M1-like) but high mitochondrial respiration and lysosomal activity (M2-like).
• BCAA Catabolism: A critical finding is the upregulation of BCAA catabolism. Enzymes like BCKDHB (rate-limiting in BCAA breakdown) and transporters (SLC7A7/8) were significantly elevated. This pathway is essential for fueling the increased energy demands of erythrophagocytosis.

C. The Signaling Axis: Low Hepcidin → High FPN → SYK → Ca²⁺

The study elucidated a specific signaling cascade driving these adaptations:

1. Low Hepcidin: Systemic ID leads to low hepcidin, preventing the degradation of Ferroportin (FPN).
2. High FPN: RPMs upregulate surface FPN to export iron.
3. Ca²⁺ Signaling: High FPN activity correlates with elevated intracellular Ca²⁺ levels. This is not due to direct Ca²⁺ transport by FPN (the D39A mutant still worked) but likely an indirect signaling effect.
4. SYK Kinase Activation: Elevated Ca²⁺ activates Spleen Tyrosine Kinase (SYK).
   • Inhibition of SYK (using ENTO) or FPN (using PR73/Vamifeport) abolishes the enhanced erythrophagocytosis, mitochondrial respiration, and BCAA catabolism.
   • SYK activity is required for the upregulation of BCKDHB and CPT2 (β-oxidation).

D. Metabolic Dependency

• BCAA Requirement: Inhibiting BCAA catabolism (ERG240) in ID mice in vivo reversed the enhanced erythrophagocytosis and reduced mitochondrial mass/activity.
• Fuel Switching: ID RPMs utilize a broad range of substrates (glucose, fatty acids, amino acids), but BCAA catabolism is specifically required to sustain the high OXPHOS state necessary for rapid RBC clearance.

4. Results Summary

• Phenotype: ID mice have enhanced RPM clearance of RBCs, driven by expanded mitochondria and lysosomes.
• Driver: The Hepcidin-FPN axis is the primary regulator. Low hepcidin stabilizes FPN, which triggers a SYK-dependent signaling cascade.
• Metabolism: This cascade reprograms RPMs to rely heavily on BCAA catabolism and β-oxidation to generate ATP for the energetically costly process of erythrophagocytosis.
• Intervention: Blocking SYK or BCAA catabolism in ID mice reduces RBC clearance, leading to a compensatory increase in erythropoietin (EPO) and stress erythropoiesis, confirming that the RPM adaptation is crucial for maintaining systemic iron homeostasis.

5. Significance

• Novel Mechanism: This study identifies a non-canonical metabolic reprogramming in macrophages that is distinct from standard inflammatory or anti-inflammatory activation states.
• Physiological Insight: It reveals how the body prioritizes iron recycling during scarcity: by hyper-activating the specific macrophage subset responsible for RBC clearance through a dedicated FPN-SYK-BCAA axis.
• Therapeutic Implications:
  • Understanding this pathway could inform treatments for anemia of chronic disease or iron-refractory anemias where this adaptive loop might be dysregulated.
  • It highlights SYK and BCAA metabolism as potential targets for modulating macrophage function in iron-related pathologies.
• Broader Context: The findings suggest that other efferocytic macrophage subsets may utilize similar signaling circuits (FPN-SYK) to adapt to metabolic stress, expanding our understanding of macrophage plasticity beyond the spleen.

In conclusion, the paper demonstrates that iron deficiency triggers a ferroportin-SYK-BCAA axis in splenic red pulp macrophages, rewiring their metabolism to fuel enhanced erythrophagocytosis and sustain systemic iron homeostasis.